We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NPPA Seeks Pricing Data on Generic Cancer Drugs Ahead of Fee Caps
NPPA Seeks Pricing Data on Generic Cancer Drugs Ahead of Fee Caps
India’s National Pharmaceutical Pricing Authority asked six manufacturers of generic cancer drugs to submit pricing data in advance of its setting price caps on the products, a move that one industry observer says was expected.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor